{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:08:09Z","timestamp":1790662089425,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T00:00:00Z","timestamp":1368662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1038\/jhg.2013.48","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T02:18:49Z","timestamp":1368670729000},"page":"548-552","source":"Crossref","is-referenced-by-count":109,"title":["Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study"],"prefix":"10.1038","volume":"58","author":[{"given":"Takahito","family":"Inoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimitoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,16]]},"reference":[{"key":"BFjhg201348_CR1","volume-title":"Alpha-galactosidase A Deficiency: Fabry Disease, in The Metabolic and Molecular Bases of Inherited Disease","author":"RJ Desnick","year":"2001","unstructured":"Desnick, R. J., Ioannou, Y. A. & Eng, C. M. Alpha-galactosidase A Deficiency: Fabry Disease, in The Metabolic and Molecular Bases of Inherited Disease 8th edn eds Scriver C. R., Beaudet A. L., Sly W. S., Valle D., 3733\u20133774 (McGraw-Hill: New York, NY, 2001)."},{"key":"BFjhg201348_CR2","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/qjmed\/hcq117","volume":"103","author":"A Mehta","year":"2010","unstructured":"Mehta, A., Beck, M., Eyskens, F., Feliciani, C., Kantola, I., Ramaswami, U. et al. Fabry disease: a review of current management strategies. QJM. 103, 641\u2013659 (2010).","journal-title":"QJM."},{"key":"BFjhg201348_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ajmg.c.30291","volume":"157","author":"K Nakamura","year":"2011","unstructured":"Nakamura, K., Hattori, K. & Endo, F. Newborn screening for lysosomal storage disorders. Am. J. Med. Genet. C. Semin. Med. Genet. 157, 63\u201371 (2011).","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"BFjhg201348_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/08035250500275022","volume":"95","author":"U Ramaswami","year":"2006","unstructured":"Ramaswami, U., Whybra, C., Parini, R., Pintos-Morell, G., Mehta, A., Sunder-Plassmann, G. et al. Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey. Acta. Paediatr. 95, 86\u201392 (2006).","journal-title":"Acta. Paediatr."},{"key":"BFjhg201348_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","volume":"30","author":"CM Eng","year":"2007","unstructured":"Eng, C. M., Fletcher, J., Wilcox, W. R., Waldek, S., Scott, C. R., Sillence, D. O. et al. Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. J. Inherit. Metab. Dis. 30, 184\u2013192 (2007).","journal-title":"J. Inherit. Metab. Dis."},{"key":"BFjhg201348_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00439-005-1300-5","volume":"117","author":"F Matsuzawa","year":"2005","unstructured":"Matsuzawa, F., Aikawa, S., Doi, H., Okumiya, T. & Sakuraba, H. Fabry disease: correlation between structural changes in alpha-galactosidase, and clinical and biochemical phenotypes. Hum. Genet. 117, 317\u2013328 (2005).","journal-title":"Hum. Genet."},{"key":"BFjhg201348_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng, C. M., Guffon, N., Wilcox, W. R., Germain, D. P., Lee, P., Waldek, S. et al. Safety and efficacy of recombinant human alpha-galactosidase A\u2014replacement therapy in Fabry\u2019s disease. N. Engl. J. Med. 345, 9\u201316 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFjhg201348_CR8","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann, R., Kopp, J. B., Austin, H. A. 3rd, Sabnis, S., Moore, D. F., Weibel, T. et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285, 2743\u20132749 (2001).","journal-title":"JAMA"},{"key":"BFjhg201348_CR9","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1365-2362.2004.01424.x","volume":"34","author":"M Beck","year":"2004","unstructured":"Beck, M., Ricci, R., Widmer, U., Dehout, F., de Lorenzo, A. G., Kampmann, C. et al. Fabry disease: overall effects of agalsidase alfa treatment. Eur. J. Clin. Invest. 34, 838\u2013844 (2004).","journal-title":"Eur. J. Clin. Invest."},{"key":"BFjhg201348_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1086\/422366","volume":"75","author":"WR Wilcox","year":"2004","unstructured":"Wilcox, W. R., Banikazemi, M., Guffon, N., Waldek, S., Lee, P., Linthorst, G. E. et al. Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. Am. J. Hum. Genet. 75, 65\u201374 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg201348_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","volume":"146","author":"M Banikazemi","year":"2007","unstructured":"Banikazemi, M., Bultas, J., Waldek, S., Wilcox, W. R., Whitley, C. B., McDonald, M. et al. Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann. Intern. Med. 146, 77\u201386 (2007).","journal-title":"Ann. Intern. Med."},{"key":"BFjhg201348_CR12","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","volume":"108","author":"F Weidemann","year":"2003","unstructured":"Weidemann, F., Breunig, F., Beer, M., Sandstede, J., Turschner, O., Voelker, W. et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 108, 1299\u20131301 (2003).","journal-title":"Circulation"},{"key":"BFjhg201348_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0009-8981(01)00478-8","volume":"308","author":"NA Chamoles","year":"2001","unstructured":"Chamoles, N. A., Blanco, M. & Gaggioli, D. Fabry disease: enzymatic diagnosis in dried blood spots on filter paper. Clin. Chim. Acta. 308, 195\u2013196 (2001).","journal-title":"Clin. Chim. Acta."},{"key":"BFjhg201348_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/jhg.2010.18","volume":"55","author":"K Nakamura","year":"2010","unstructured":"Nakamura, K., Sekijima, Y., Nakamura, K., Hattori, K., Nagamatsu, K., Shimizu, Y. et al. Cerebral hemorrhage in Fabry's disease. J. Hum. Genet. 55, 259\u2013261 (2010).","journal-title":"J. Hum. Genet."},{"key":"BFjhg201348_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1096-7192(02)00012-4","volume":"76","author":"J Shabbeer","year":"2002","unstructured":"Shabbeer, J., Yasuda, M., Luca, E. & Desnick, R. J. Fabry disease: 45 novel mutations in the alpha-galactosidase A gene causing the classical phenotype. Mol. Genet. Metab. 76, 23\u201330 (2002).","journal-title":"Mol. Genet. Metab."},{"key":"BFjhg201348_CR16","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1086\/339431","volume":"70","author":"S Ishii","year":"2002","unstructured":"Ishii, S., Nakao, S., Minamikawa-Tachino, R., Desnick, R. J. & Fan, J. Q. Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype. Am. J. Hum. Genet. 70, 994\u20131002 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg201348_CR17","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/humu.21074","volume":"30","author":"WL Hwu","year":"2009","unstructured":"Hwu, W. L., Chien, Y. H., Lee, N. C., Chiang, S. C., Dobrovolny, R., Huang, A. C. et al. Newborn screening for Fabry disease in Taiwan reveals a high incidence of the lateronset GLA mutation c.936+919G4A (IVS4+919G4A). Hum. Mutat. 30, 1397\u20131405 (2009).","journal-title":"Hum. Mutat."},{"key":"BFjhg201348_CR18","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/jhg.2010.58","volume":"55","author":"BH Lee","year":"2010","unstructured":"Lee, B. H., Heo, S. H., Kim, G.-W., Park, J.-Y., Kim, W.-S., Kang, D. H. et al. Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns. J. Hum. Genet. 55, 512\u2013517 (2010).","journal-title":"J. Hum. Genet."},{"key":"BFjhg201348_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ymgme.2012.01.010","volume":"105","author":"T Togawa","year":"2012","unstructured":"Togawa, T., Tsukimura, T., Kodama, T., Tanaka, T., Kawashima, I., Saito, S. et al. Fabry disease: Biochemical, pathological and structural studies of the \u03b1-galactosidase A with E66Q amino acid substitution. Mol. Genet. Metab. 105, 615\u2013620 (2012).","journal-title":"Mol. Genet. Metab."},{"key":"BFjhg201348_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/jmg.30.8.658","volume":"30","author":"JP Davies","year":"1993","unstructured":"Davies, J. P., Winchester, B. G. & Malcolm, S. Sequence variations in the first exon of alpha-galactosidase A. J. Med. Genet. 30, 658\u2013663 (1993).","journal-title":"J. Med. Genet."},{"key":"BFjhg201348_CR21","doi-asserted-by":"publisher","first-page":"S405","DOI":"10.1007\/s10545-008-0972-0","volume":"31","author":"JP Oliveira","year":"2008","unstructured":"Oliveira, J. P., Ferreira, S., Reguenga, C., Carvalho, F. & M\u00e5nsson, J. E. The g.1170C>T polymorphism of the 5\u2032 untranslated region of the human alpha-galactosidase gene is associated with decreased enzyme expression\u2014evidence from a family study. J. Inherit. Metab. Dis. 31, S405\u2013S413 (2008).","journal-title":"J. Inherit. Metab. Dis."},{"key":"BFjhg201348_CR22","doi-asserted-by":"publisher","first-page":"S247","DOI":"10.1007\/s10545-008-0818-9","volume":"31","author":"JP Oliveira","year":"2008","unstructured":"Oliveira, J. P., Ferreira, S., Barcel\u00f3, J., Gaspar, P., Carvalho, F., S\u00e1 Miranda, M. C. et al. Effect of single-nucleotide polymorphisms of the 5\u2032 untranslated region of the human \u03b1-galactosidase gene on enzyme activity, and their frequencies in Portuguese caucasians. J. Inherit. Metab. Dis. 31, S247\u2013S253 (2008).","journal-title":"J. Inherit. Metab. Dis."},{"key":"BFjhg201348_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada, M., Pagliardini, S., Yasuda, M., Tukel, T., Thiagarajan, G., Sakuraba, H. et al. High incidence of later-onset Fabry disease revealed by newborn screening. Am. J. Hum. Genet. 79, 31\u201340 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg201348_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0140-6736(11)61266-X","volume":"379","author":"TP Mechtler","year":"2012","unstructured":"Mechtler, T. P., Stary, S., Metz, T. F., De Jes\u00fas, V. R., Greber-Platzer, S., Pollak, A. et al. Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria. Lancet 379, 335\u2013341 (2012).","journal-title":"Lancet"},{"key":"BFjhg201348_CR25","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10545-011-9435-0","volume":"35","author":"LF Ross","year":"2012","unstructured":"Ross, L. F. Newborn screening for lysosomal storage diseases: an ethical and policy analysis. J. Inherit. Metab. Dis. 35, 627\u2013634 (2012).","journal-title":"J. Inherit. Metab. Dis."},{"key":"BFjhg201348_CR26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1542\/peds.2005-2895","volume":"118","author":"M Ries","year":"2006","unstructured":"Ries, M., Clarke, J. T., Whybra, C., Timmons, M., Robinson, C., Schlaggar, B. L. et al. Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease. Pediatrics 118, 924\u2013932 (2006).","journal-title":"Pediatrics"},{"key":"BFjhg201348_CR27","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1177\/0091270007305299","volume":"47","author":"M Ries","year":"2007","unstructured":"Ries, M., Clarke, J. T., Whybra, C., Mehta, A., Loveday, K. S., Brady, R. O. et al. Enzyme replacement in Fabry disease: pharmacokinetics and pharmacodynamics of agalsidase alpha in children and adolescents. J. Clin. Pharmacol. 47, 1222\u20131230 (2007).","journal-title":"J. Clin. Pharmacol."},{"key":"BFjhg201348_CR28","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jpeds.2009.11.007","volume":"156","author":"R Schiffmann","year":"2010","unstructured":"Schiffmann, R., Martin, R. A., Reimschisel, T., Johnson, K., Castaneda, V., Lien, Y. H. et al. Four-year prospective clinical trial of agalsidase alfa in children with Fabry disease. J. Pediatr. 156, 832\u2013837 (2010).","journal-title":"J. Pediatr."},{"key":"BFjhg201348_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1651-2227.2007.00029.x","volume":"96","author":"U Ramaswami","year":"2007","unstructured":"Ramaswami, U., Wendt, S., Pintos-Morell, G., Parini, R., Whybra, C., Leon Leal, J. A. et al. Enzyme replacement therapy with agalsidase alfa in children with Fabry disease. Acta. Paediatr. 96, 122\u2013127 (2007).","journal-title":"Acta. Paediatr."},{"key":"BFjhg201348_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/DDDT.S11985","volume":"5","author":"U Ramaswami","year":"2011","unstructured":"Ramaswami, U. Update on role of agalsidase alfa in management of Fabry disease. Drug Des. Devel. Ther. 5, 155\u2013173 (2011).","journal-title":"Drug Des. Devel. Ther."},{"key":"BFjhg201348_CR31","unstructured":"The Japanese Association of Medical Sciences \u201cGuidelines for Genetic Tests and Diagnoses in Medical Practice\u201d \n                    http:\/\/jams.med.or.jp\/guideline\/genetics-diagnosis_e.pdf\n                    \n                  ."},{"key":"BFjhg201348_CR32","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.jpeds.2009.07.004","volume":"155","author":"AM Martins","year":"2009","unstructured":"Martins, A. M., Valadares, E. R., Porta, G., Coelho, J., Semionato Filho, J., Pianovski, M. A. et al. Recommendations on diagnosis, treatment, and monitoring for Gaucher disease. J. Pediatr. 155, S10\u2013S18 (2009).","journal-title":"J. Pediatr."},{"key":"BFjhg201348_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/mus.22329","volume":"45","author":"EJ Cupler","year":"2012","unstructured":"Cupler, E. J., Berger, K. I., Leshner, R. T., Wolfe, G. I., Han, J. J., Barohn, R. J. et al. Consensus treatment recommendations for late-onset Pompe disease. Muscle Nerve 45, 319\u2013333 (2012).","journal-title":"Muscle Nerve"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhg201348.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg201348","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg201348.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:31:51Z","timestamp":1684416711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg201348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,16]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["BFjhg201348"],"URL":"https:\/\/doi.org\/10.1038\/jhg.2013.48","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,16]]}}}